Does a low kynurenic-to-quinolinic acid ratio reflect a neurotoxic inflammatory balance?

Mechanistic pathways of kynurenine balance

• Opposing NMDA receptor modulation: Quinolinic acid (QUIN) is an endogenous agonist targeting the glutamate-binding site of NMDA receptors (specifically GluN2A and GluN2B subunits), triggering sustained intracellular calcium influx. Conversely, kynurenic acid (KYNA) is an endogenous antagonist that competitively blocks the receptor's glycine co-agonist site.
• Cellular origins and dynamics: KYNA is synthesized primarily by astrocytes and exhibits neuroprotective inhibition with an IC50 of 10–30 µM under low-glycine conditions. QUIN is produced by activated microglia and macrophages; although it acts as a weak partial agonist requiring higher concentrations (EC50 of 2–3 mM) for baseline activation, its localized accumulation drives significant neurotoxicity.
• Oxidative and cellular damage: Beyond NMDA receptor overactivation, elevated QUIN levels directly promote lipid peroxidation, mitochondrial compromise, and free radical generation, compounding neuronal vulnerability.

Inflammatory drive and clinical implications

• Cytokine-driven metabolic shift: Pro-inflammatory cytokines, particularly interferon-gamma (IFN-γ), upregulate indoleamine 2,3-dioxygenase (IDO). This enzymatic activation shifts kynurenine metabolism away from astrocyte-derived KYNA production toward microglial-derived QUIN synthesis.
• Biomarker of neurotoxicity: A decreased KYNA/QUIN ratio serves as a robust clinical index of neuroinflammatory and excitotoxic states. Lower ratios in blood and cerebrospinal fluid correlate with neurodegenerative disorders, major depressive disorder, and age-related cognitive decline.

Bottom line

• Bottom line: The claim is fully supported. A low kynurenic-to-quinolinic acid ratio directly reflects an active metabolic shift toward a neurotoxic, microglial-driven inflammatory state, where the protective NMDA-blocking effects of kynurenic acid are overwhelmed by the excitotoxic and pro-oxidant actions of quinolinic acid.